IP Verse

Use Of Pilocarpine Hydrochloride For The Treatment Of Ocular Conditions

Patent No. EP3681500 (titled "Use Of Pilocarpine Hydrochloride For The Treatment Of Ocular Conditions") was filed by Allergan on Apr 24, 2019. The application was issued on Jul 30, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSDec 20, 2022KRAUS & LEDERER PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3681500

ALLERGAN
Application Number
EP19729883A
Filing Date
Apr 24, 2019
Status
Patent Maintained As Amended
Jun 27, 2025
Publication Date
Jul 30, 2025
External Links
Slate, Register , Google Patents